We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00562653
Recruitment Status : Unknown
Verified November 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : November 22, 2007
Last Update Posted : November 22, 2007
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.

Condition or disease
Infective Endocarditis

Study Design

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Study of Autoantibodies in Infective Endocarditis
Study Start Date : November 2007
Estimated Study Completion Date : November 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endocarditis
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
1
infective endocarditis patients before treatment
2
infective endocarditis treatment after treatment
3
control


Outcome Measures

Biospecimen Retention:   None Retained
serum

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
infective endocarditis patients
Criteria

Inclusion Criteria:

  • Infective endocarditis patients by DUKES criteria

Exclusion Criteria:

  • HIV positive
  • Patients suffering from other infective diseases other than endocarditis.
  • Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00562653


Locations
Israel
Sourasky Medical Center Not yet recruiting
Tel-Aviv, Israel
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Ministry of Health, Israel
Investigators
Principal Investigator: Victoria Bogusllavsky, MD Sourasky Medical Center, Internal Medicine
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00562653     History of Changes
Other Study ID Numbers: sourasky medical centrs
First Posted: November 22, 2007    Key Record Dates
Last Update Posted: November 22, 2007
Last Verified: November 2007

Keywords provided by Tel-Aviv Sourasky Medical Center:
profile autoantibodies
clinical symptoms

Additional relevant MeSH terms:
Endocarditis
Endocarditis, Bacterial
Heart Diseases
Cardiovascular Diseases
Bacterial Infections
Cardiovascular Infections
Infection
Autoantibodies
Immunologic Factors
Physiological Effects of Drugs